130 related articles for article (PubMed ID: 12037507)
1. [Glitazones and weight gain].
Scheen A
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S41-4. PubMed ID: 12037507
[No Abstract] [Full Text] [Related]
2. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
Lotz N
MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
[No Abstract] [Full Text] [Related]
3. [Insulin sensitizer drugs--review].
Yamanouchi T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():409-15. PubMed ID: 12387026
[No Abstract] [Full Text] [Related]
4. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
5. [Value of glitazones in therapy of type 2 diabetes: pro].
Pfohl M
Dtsch Med Wochenschr; 2001 May; 126(20):605. PubMed ID: 11402928
[No Abstract] [Full Text] [Related]
6. Rosiglitazone--useful drug but has side effects.
Vidhya S; Mohan V
J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
[No Abstract] [Full Text] [Related]
7. [Glitazones--a new therapeutic principle in diabetes].
Birkeland KI
Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2617-9. PubMed ID: 11668762
[No Abstract] [Full Text] [Related]
8. Thiazolidinediones in diabetes: current status and future outlook.
Camp HS
Curr Opin Investig Drugs; 2003 Apr; 4(4):406-11. PubMed ID: 12808879
[TBL] [Abstract][Full Text] [Related]
9. Glitazones, glycemia, and global health status.
Isley WL
Diabetes Care; 2001 Dec; 24(12):2158-9. PubMed ID: 11723105
[No Abstract] [Full Text] [Related]
10. [Use of glitazones in type 2 diabetes: a critical position].
Richter B
Dtsch Med Wochenschr; 2001 May; 126(20):606. PubMed ID: 11402929
[No Abstract] [Full Text] [Related]
11. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
12. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
13. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
14. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
15. Glitazones: clinical effects and molecular mechanisms.
Stumvoll M; Häring HU
Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
[TBL] [Abstract][Full Text] [Related]
16. [Causal therapy of type 2 diabetes. Determining the cause of insulin resistance early].
MMW Fortschr Med; 2000 Nov; 142(47):56. PubMed ID: 11143782
[No Abstract] [Full Text] [Related]
17. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
18. [Medication of the month. Rosiglitazone (Avandia)].
Scheen AJ
Rev Med Liege; 2002 Apr; 57(4):236-9. PubMed ID: 12073798
[TBL] [Abstract][Full Text] [Related]
19. [Tackling insulin resistance. Control of etiology in type 2 diabetes].
MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300
[No Abstract] [Full Text] [Related]
20. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
Böhm S
MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
